These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15236925)

  • 1. The diagnosis of acute hepatitis C virus infection during seroconversion: an important therapeutic opportunity.
    McMullan R; Coyle PV; Feeney S; McCaughey C; Gregg W; McDougall N
    J Infect; 2004 Aug; 49(2):165-8. PubMed ID: 15236925
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune hepatitis and/or hepatitis C: how to decide.
    Schapiro GD; Friedman LS
    Hepatology; 1996 Mar; 23(3):647-9. PubMed ID: 8617449
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-laboratory characteristics of acute viral hepatitis C in parenteral drug addicts].
    Kozhevnikova GM; Roslyĭ IM; Chuĭkova KI; Bobkova MR
    Ter Arkh; 1999; 71(11):10-4. PubMed ID: 10626325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnostics in hepatitis C virus infection: clinical applications. Scientific Committee--"Tecnologie molecolari nella diagnostica delle epatopatie" of the Italian Association for the Study of the Liver-AISF.
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):191-4. PubMed ID: 9646205
    [No Abstract]   [Full Text] [Related]  

  • 6. Laboratory approaches to the diagnosis of hepatitis C virus infection.
    Jerome KR; Gretch DR
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):9-20. PubMed ID: 15719002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.
    Lemos LB; Perez RM; Matos CA; Silva IS; Silva AE; Ferraz ML
    J Clin Gastroenterol; 2008 Feb; 42(2):208-11. PubMed ID: 18209594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.
    Wang CC; Krantz E; Klarquist J; Krows M; McBride L; Scott EP; Shaw-Stiffel T; Weston SJ; Thiede H; Wald A; Rosen HR
    J Infect Dis; 2007 Nov; 196(10):1474-82. PubMed ID: 18008226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic tests for the hepatitis C virus].
    Sjorgen MH
    Rev Gastroenterol Mex; 1995; 60(4 Suppl 2):S46-8. PubMed ID: 8948777
    [No Abstract]   [Full Text] [Related]  

  • 11. In situ identification of hepatitis C virus RNA in muscle.
    Ito H; Ito H; Nagano M; Nakano S; Shigeyoshi Y; Kusaka H
    Neurology; 2005 Mar; 64(6):1073-5. PubMed ID: 15781833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
    D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
    Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of hepatitis C virus after newly acquired infection in injection drug users.
    Jauncey M; Micallef JM; Gilmour S; Amin J; White PA; Rawlinson W; Kaldor JM; van Beek I; Dore GJ
    J Infect Dis; 2004 Oct; 190(7):1270-4. PubMed ID: 15346337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC issues new recommendations for the prevention and control of hepatitis C virus infection.
    Rose VL
    Am Fam Physician; 1999 Mar; 59(5):1321-3. PubMed ID: 10088882
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
    Hussein MM; Mooij JM; Hegazy MS; Bamaga MS
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of molecular biology investigations in the detection of Hepatitis C virus].
    Miseta A
    Orv Hetil; 2002 Jun; 143(24):1507. PubMed ID: 12138649
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of virologic assays in the diagnosis and management of hepatitis C virus infection.
    Chevaliez S; Pawlotsky JM
    Clin Liver Dis; 2005 Aug; 9(3):371-82, v. PubMed ID: 16023971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral evolution of hepatitis C in injection drug users.
    Dove L; Phung Y; Bzowej N; Kim M; Monto A; Wright TL
    J Viral Hepat; 2005 Nov; 12(6):574-83. PubMed ID: 16255758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.
    Satoh Y; Hino K; Kato T; Mizokami M; Yamashita S; Nakamura H; Okita K
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1305-11. PubMed ID: 15482539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA issues final guidance on nucleic acid tests.
    AIDS Alert; 2005 Apr; 20(4):46-7. PubMed ID: 15844224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.